These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 119076)

  • 21. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit.
    Mayank D; Anshuman M; Singh RK; Afzal A; Baronia AK; Prasad KN
    Indian J Pathol Microbiol; 2009; 52(4):509-13. PubMed ID: 19805958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant form of Pseudomonas aeruginosa in sputum and cerebrospinal fluid causing infection in a compromised patient.
    Middleton J; Chmel H
    J Clin Pathol; 1978 Apr; 31(4):351-4. PubMed ID: 417094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa].
    Baĭgozina EA
    Klin Med (Mosk); 2009; 87(6):57-9. PubMed ID: 19670720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes.
    Wang CY; Jerng JS; Chen KY; Lee LN; Yu CJ; Hsueh PR; Yang PC
    Clin Microbiol Infect; 2006 Jan; 12(1):63-8. PubMed ID: 16460548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens].
    Shigeta S; Goto S; Ishida N
    Rinsho Byori; 1971 Jan; 19(1):77-80. PubMed ID: 4996146
    [No Abstract]   [Full Text] [Related]  

  • 28. Biofilm dispersal and exacerbations of cystic fibrosis lung disease.
    Reid DW; Kirov SM; Webb JS; Carroll V; Kjelleberg S; Champion A; Sanderson K
    Pediatr Pulmonol; 2006 Dec; 41(12):1254; author reply 1255. PubMed ID: 17068827
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pneumonia caused by Pseudomonas aeruginosa. Clinical review of a series of 40 patients].
    Conde Yagüe R; García-Cobo J; Lomba Falcón JM; Ledesma Castaño F; Gorjón de la Cruz V; García Moncó C
    Rev Clin Esp; 1982 Feb; 164(4):253-7. PubMed ID: 6806875
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotic sensitivity and plasmid profiles of Pseudomonas aeruginosa.
    Igumbor E; Gwanzura L; Chirara M; Obi C; Muza D
    Cent Afr J Med; 2000 Nov; 46(11):296-300. PubMed ID: 12002119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of systemic antibiotic in preventing sequential endogenous endophthalmitis of a bronchiectasis patient.
    Chan WM; Liu DT; Fan DS; Lau TT; Lam DS
    Am J Ophthalmol; 2005 Mar; 139(3):549-50. PubMed ID: 15767074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isdolated from clinical specimens].
    Shigeta S; Goto S; Ishida N
    Rinsho Byori; 1971 Jan; 19(1):77-80. PubMed ID: 4996147
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia].
    Deng GH
    Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):599-601, 637. PubMed ID: 8313182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Netilmicin in the treatment of Pseudomonas bacteremia.
    Lorber RR; Linzmayer MI
    Clin Ther; 1985; 7(3):338-46. PubMed ID: 3922616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
    Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
    Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
    Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa.
    Guibert JM; Destree DM; Acar JF
    Chemioterapia; 1987 Jun; 6(2 Suppl):524-5. PubMed ID: 3151352
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pubic osteitis caused by Pseudomonas aeruginosa].
    Arlet J; Arlet-Suau E; Carles P; Sebbag D; Mazières B; Durroux R
    Rev Rhum Mal Osteoartic; 1978 Dec; 45(12):725-8. PubMed ID: 107573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.